Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
ruStkAzV1gZd46dE
